Argentina vs Namibia: Adults (ages 15+) and children (ages 0-14) newly infected with HIV
Argentina
4,900
in 2024
Namibia
4,500
in 2024
Argentina rank
33rd
Namibia rank
35th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV over time
- Argentina
- Namibia
How they compare
Argentina currently reports 4,900 against 4,500 in Namibia, a difference of 400.
That makes Argentina's figure about 1.1 times Namibia's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Namibia ahead.
Argentina ranks 33rd and Namibia ranks 35th of 146 countries.
Across the 4 decades both report, Argentina averaged higher in 1 and Namibia in 3.
Head to head by decade
| Decade | Argentina | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5,570 | 16,460 | 10,890 | Namibia |
| 2000s | 5,600 | 15,600 | 10,000 | Namibia |
| 2010s | 5,310 | 8,410 | 3,100 | Namibia |
| 2020s | 5,000 | 4,600 | 400 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (ages 0-14) newly infected with hiv, Argentina or Namibia?
- Argentina, at 4,900 against 4,500 in Namibia as of 2024.
- What is the difference in adults (ages 15+) and children (ages 0-14) newly infected with hiv between Argentina and Namibia?
- 400, with Argentina ahead.
- How many years of comparable data are there for Argentina and Namibia?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Namibia rank globally for adults (ages 15+) and children (ages 0-14) newly infected with hiv?
- Argentina ranks 33rd and Namibia ranks 35th of 146 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15+) and children (ages 0-14) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.